Major Pharmaceuticals recalled Gabapentin Capsules, USP, 100 mg, 10 capsules per blister pack, distributed nationwide in the United States. The recall cites failed impurities and degradation specifications from routine stability testing, specifically an out-of-spec Highest Unknown Impurity. Consumers and healthcare providers should stop using this product immediately and contact The Harvard Drug集团
Failed Impurities/Degradation Specifications: an out of specification result obtained during routine stability testing for Highest Unknown Impurity .
Consumers and healthcare providers should stop using this product immediately. Contact The Harvard Drug Group LLC or your healthcare provider for guidance
Get instant alerts for Health & Personal Care recalls
Be the first to know. Free instant alerts to your inbox.
Gabapentin is a prescription medication used to treat nerve pain and seizures. This recall involves a 100 mg capsule sold in 10-count blister packs and distributed nationwide in the US.
A stability test identified an out-of-spec Highest Unknown Impurity, prompting the recall due to potential safety risk.
This recall is not described as part of a broader industry pattern in the notice.
The recall may disrupt treatment for patients currently using these lots. Patients must stop use and consult a healthcare provider for guidance.
FDA recall enforcement page at https://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?recall_number=D-0031-2026
Recall does not specify refund/replacement timelines. Typically 4-8 weeks for processing disruptions may occur.
Keep the original packaging, lot number, expiration date, purchase receipts if available, and all correspondence with the provider or distributor.
Product: Gabapentin Capsules, USP, 100 mg, 10 capsules per blister pack. Rx only. Distributor: Major Pharmaceuticals, Indianapolis, IN 46268, USA. NDCs: 0904-6665-61 (Blister pack), 55154-3363-0 (Outer Bag). Lot numbers: M04989A, M05056A, M05150A, M05312A, M05342A. Expiration dates: 02/2026, 04/2026, 07/2026, 01/2027. Sold nationwide in the US.
No injuries or incidents have been reported.
Not sure what to do next? Our guide walks you through the process step by step.
Read: What to Do When You Find a Recalled ProductGet instant alerts for recalls that affect you. Free forever.
Major Pharmaceuticals recalled Gabapentin capsules, 100 mg, 100-count, distributed nationwide in the United States. The recall stems from an out-of-spec highest unknown impurity found during stability testing. Healthcare providers and patients should stop using the product and contact The Harvard Drug Group LLC for guidance.
Major Pharmaceuticals, via The Harvard Drug Group LLC, recalled 506 blister packs of Chlorpromazine Hydrochloride tablets, 50 mg, distributed nationwide. A CGMP deviation shows the presence of N-Nitroso Desmethyl Chlorpromazine above the recommended intake limit. Stop using the product and contact the Harvard Drug Group or Rugby Laboratories for guidance.
Major Pharmaceuticals recalled 1,394 blister packs of Chlorpromazine Hydrochloride Tablets, 200 mg, distributed nationwide. The recall cites CGMP deviations with the presence of N-Nitroso Desmethyl Chlorpromazine above the recommended intake limit. Healthcare providers and patients are urged to stop using the product and await guidance from Major Pharmaceuticals and Rugby Laboratories.
Major Pharmaceuticals recalled 1,256 blister packs of Chlorpromazine Hydrochloride tablets, 25 mg, sold nationwide in the United States. A CGMP deviation led to the presence of N-Nitroso Desmethyl Chlorpromazine above the recommended intake. Healthcare providers and patients should stop using the product and contact Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories for next-步
Major Pharmaceuticals recalled 866 Chlorpromazine Hydrochloride 100 mg tablets distributed nationwide after CGMP deviations allowed N-Nitroso Desmethyl Chlorpromazine above the recommended intake limit. The impurity detected raises safety concerns for ongoing use. Stop using the product immediately and contact Harvard Drug Group LLC dba Major Pharmaceuticals or Rugby Laboratories for guidance and,
Major Pharmaceuticals recalled 2,064 blister packs of Chlorpromazine Hydrochloride Tablets, 25 mg, sold nationwide through healthcare providers. The recall follows CGMP deviations that allowed the presence of N-Nitroso Desmethyl Chlorpromazine above the allowed limit. Stop using the product immediately and await guidance from Major Pharmaceuticals or your healthcare provider.
A high-risk recall of sulfamethoxazole and trimethoprim 800 mg/160 mg double-strength tablets is active nationwide in the United States. The Harvard Drug Group and distribution partners have halted use of a lot due to a foreign-substance finding in packaging material. No tablets tested positive for micro-organisms. Consumers should stop using the product and consult their healthcare providers.
The FDA recalls 26,628 cartons of Carvedilol Tablets USP 12.5 mg distributed nationwide. The product fails CGMP standards due to NNCI impurity exceeding FDA limits. Stop using and contact The Harvard Drug Group LLC and Rugby Laboratories for guidance.